HNSBF - Hansa Biopharma GAAP EPS of -SEK 3.45 revenue of SEK 67M October, 20 2022 03:47 AM Hansa Biopharma AB Hansa Biopharma press release ( OTCPK:HNSBF ): Q3 GAAP EPS of -SEK 3.45. Revenue of SEK 67M (+1253.5% Y/Y). For further details see: Hansa Biopharma GAAP EPS of -SEK 3.45, revenue of SEK 67M